Get the Stockscreener App
0.0006
99.60%
-0.1494
IN VERITAS MED DIAGNOSTIC Stock (IVME) Forecast
The IN VERITAS MED DIAGNOSTIC (IVME) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.0454, representing a +7,460% increase from the current price of $0.0006. The highest analyst price target is $0.0481, and the lowest is $0.0427.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IVME Price Target
Average 0.0598
(+9,863% Upside)
Long-term IVME price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about IN VERITAS MED DIAGNOSTIC financial reports and earnings history, IN VERITAS MED DIAGNOSTIC (IVME) stock could reach $0.1525 by 2030, $0.3709 by 2040 and $0.5344 by 2050. See the projected annual prices until 2050 of the IN VERITAS MED DIAGNOSTIC stock below:
- IN VERITAS MED DIAGNOSTIC (IVME) is expected to reach an average price of $0.2403 in 2035, with a high prediction of $0.2617 and a low estimate of $0.195. This indicates an $39,950% rise from the last recorded price of $0.0006.
- IN VERITAS MED DIAGNOSTIC (IVME) stock is projected to chart a bullish course in 2040, with an average price target of $0.3101, representing an $51,591% surge from its current level. The forecast ranges from a conservative $0.3101 to a sky-high $0.3709.
- Our analysts predict IN VERITAS MED DIAGNOSTIC (IVME) to jump 59,892% by 2045, soaring from $0.36 to an average price of $0.36, potentially reaching $0.4801. While $0.36 is the low estimate, the potential upside is significant.
- IN VERITAS MED DIAGNOSTIC (IVME) stock is expected to climb by 2050, reaching an average of $0.488, a $81,235% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.5344 and $0.4416, respectively, highlighting the market's uncertainty.
IN VERITAS MED DIAGNOSTIC Stock (IVME) Year by Year Forecast
IN VERITAS MED DIAGNOSTIC Stock (IVME) Price Forecast for 2025
IN VERITAS MED DIAGNOSTIC Stock (IVME) is expected to reach an average price of $0.0469 in 2025, with a high prediction of $0.0622 and a low estimate of $0.0317. This indicates an +7,721% rise from the last recorded price of $0.0006.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $0.0454 | $0.0427 | $0.0481 | +7,460% |
| October, 2025 | $0.0511 | $0.0442 | $0.058 | +8,419% |
| November, 2025 | $0.0458 | $0.0458 | $0.0601 | +7,532% |
| December, 2025 | $0.0533 | $0.0533 | $0.0622 | +8,785% |
IN VERITAS MED DIAGNOSTIC Stock (IVME) Price Forecast for 2026
The predicted value for IN VERITAS MED DIAGNOSTIC (IVME) in 2026 is set at an average of $0.0653. Estimates vary from a peak of $0.0832 to a trough of $0.0474, indicating an +10,780% surge from the present price of $0.0006.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0551 | $0.0474 | $0.0643 | +9,076% |
| February, 2026 | $0.0614 | $0.0489 | $0.0664 | +10,134% |
| March, 2026 | $0.0685 | $0.0505 | $0.0685 | +11,317% |
| April, 2026 | $0.0553 | $0.0521 | $0.0586 | +9,119% |
| May, 2026 | $0.0621 | $0.0536 | $0.0706 | +10,254% |
| June, 2026 | $0.0552 | $0.0552 | $0.0727 | +9,103% |
| July, 2026 | $0.0568 | $0.0568 | $0.0748 | +9,365% |
| August, 2026 | $0.0655 | $0.0655 | $0.0769 | +10,823% |
| September, 2026 | $0.0729 | $0.0584 | $0.079 | +12,057% |
| October, 2026 | $0.0749 | $0.0599 | $0.0811 | +12,378% |
| November, 2026 | $0.0832 | $0.0615 | $0.0832 | +13,767% |
| December, 2026 | $0.0669 | $0.0631 | $0.0708 | +11,055% |
IN VERITAS MED DIAGNOSTIC Stock (IVME) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for IN VERITAS MED DIAGNOSTIC (IVME) is $0.0855, with a high forecast of $0.1063 and a low forecast of $0.0646. This indicates an +14,145% increase from the last price of $0.0006.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.075 | $0.0646 | $0.0853 | +12,395% |
| February, 2027 | $0.0662 | $0.0662 | $0.0874 | +10,936% |
| March, 2027 | $0.076 | $0.076 | $0.0895 | +12,571% |
| April, 2027 | $0.0778 | $0.0678 | $0.0916 | +12,862% |
| May, 2027 | $0.0864 | $0.0694 | $0.0937 | +14,302% |
| June, 2027 | $0.0958 | $0.0709 | $0.0958 | +15,867% |
| July, 2027 | $0.0979 | $0.0725 | $0.0979 | +16,217% |
| August, 2027 | $0.0792 | $0.0741 | $0.0843 | +13,094% |
| September, 2027 | $0.0756 | $0.0756 | $0.10 | +12,507% |
| October, 2027 | $0.0772 | $0.0772 | $0.1021 | +12,768% |
| November, 2027 | $0.0883 | $0.0883 | $0.1042 | +14,609% |
| December, 2027 | $0.09 | $0.0788 | $0.1063 | +14,900% |
IN VERITAS MED DIAGNOSTIC Stock (IVME) Price Forecast for 2028
In 2028, IN VERITAS MED DIAGNOSTIC (IVME) is projected to reach an average price of $0.1038, with a high projection of $0.1273 and a low estimate of $0.0804. This indicates an +17,204% rise from the last price of $0.0006.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0999 | $0.0804 | $0.1084 | +16,546% |
| February, 2028 | $0.1105 | $0.0819 | $0.1105 | +18,317% |
| March, 2028 | $0.1126 | $0.0835 | $0.1126 | +18,667% |
| April, 2028 | $0.0914 | $0.0851 | $0.0977 | +15,132% |
| May, 2028 | $0.0866 | $0.0866 | $0.1147 | +14,339% |
| June, 2028 | $0.0882 | $0.0882 | $0.1168 | +14,601% |
| July, 2028 | $0.1005 | $0.1005 | $0.1189 | +16,647% |
| August, 2028 | $0.1114 | $0.0898 | $0.121 | +18,469% |
| September, 2028 | $0.1133 | $0.0913 | $0.1231 | +18,790% |
| October, 2028 | $0.1252 | $0.0929 | $0.1252 | +20,767% |
| November, 2028 | $0.1019 | $0.0945 | $0.1093 | +16,879% |
| December, 2028 | $0.1117 | $0.0961 | $0.1273 | +18,513% |
IN VERITAS MED DIAGNOSTIC Stock (IVME) Price Forecast for 2029
The 2029 price forecast for IN VERITAS MED DIAGNOSTIC Stock (IVME) is $0.124 on average, with a high prediction of $0.1504 and a low estimate of $0.0976. This represents an +20,569% increase from the previous price of $0.0006.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0976 | $0.0976 | $0.1294 | +16,172% |
| February, 2029 | $0.111 | $0.111 | $0.1315 | +18,395% |
| March, 2029 | $0.1127 | $0.0992 | $0.1336 | +18,686% |
| April, 2029 | $0.1249 | $0.1008 | $0.1357 | +20,714% |
| May, 2029 | $0.1378 | $0.1023 | $0.1378 | +22,867% |
| June, 2029 | $0.1399 | $0.1039 | $0.1399 | +23,217% |
| July, 2029 | $0.1141 | $0.1055 | $0.1227 | +18,918% |
| August, 2029 | $0.1245 | $0.1071 | $0.142 | +20,655% |
| September, 2029 | $0.1086 | $0.1086 | $0.1441 | +18,004% |
| October, 2029 | $0.1232 | $0.1232 | $0.1462 | +20,433% |
| November, 2029 | $0.1249 | $0.1102 | $0.1483 | +20,724% |
| December, 2029 | $0.1383 | $0.1118 | $0.1504 | +22,958% |
IN VERITAS MED DIAGNOSTIC Stock (IVME) Price Forecast for 2030
IN VERITAS MED DIAGNOSTIC Stock (IVME) is expected to reach an average price of $0.1424 in 2030, with a high forecast of $0.1714 and a low forecast of $0.1133. This signifies an +23,628% surge from the last price of $0.0006.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1525 | $0.1133 | $0.1525 | +25,317% |
| February, 2030 | $0.1246 | $0.1149 | $0.1343 | +20,665% |
| March, 2030 | $0.1355 | $0.1165 | $0.1546 | +22,490% |
| April, 2030 | $0.1181 | $0.1181 | $0.1567 | +19,575% |
| May, 2030 | $0.1196 | $0.1196 | $0.1588 | +19,837% |
| June, 2030 | $0.1354 | $0.1354 | $0.1609 | +22,471% |
| July, 2030 | $0.1499 | $0.1212 | $0.163 | +24,881% |
| August, 2030 | $0.1518 | $0.1228 | $0.1651 | +25,202% |
| September, 2030 | $0.1672 | $0.1243 | $0.1672 | +27,767% |
| October, 2030 | $0.1368 | $0.1259 | $0.1477 | +22,703% |
| November, 2030 | $0.1484 | $0.1275 | $0.1693 | +24,631% |
| December, 2030 | $0.129 | $0.129 | $0.1714 | +21,408% |
5.71%
0.34%
Cap:
|
Volume (24h):